Skip to content

13F-HR/A filed by Nextech Invest Ltd.

Nextech Invest Ltd. filed this 13F-HR/A for the quarter ended 2021-12-31, filed 2022-05-16, with 11 holding rows worth $379,574,000.

Accession
0001104659-22-060818
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, amendment of type restatement, 11 entries on the cover page, a total value of $379,574,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $379,574,000 with VALUE read as thousands by filing date, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EQRX INC26886C107COM13,104,424$89,372,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock2,968,214$74,710,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM3,008,243$53,306,000thousands by filing date
TYRA BIOSCIENCES INC90240B106COMMON STOCK2,518,582$35,436,000thousands by filing date
PMV PHARMACEUTICALS INC69353Y103COM1,385,807$32,012,000thousands by filing date
ARVINAS INC04335A105COM287,251$23,595,000thousands by filing date
KRONOS BIO INC50107A104COM1,451,537$19,726,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM1,221,145$18,842,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM1,910,029$12,721,000thousands by filing date
C4 THERAPEUTICS INC12529R107COM STK375,857$12,103,000thousands by filing date
THESEUS PHARMACEUTICALS INC88369M101COM611,310$7,751,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-022977 superseded2022-02-14acceptance time not in the bulk data set
13F-HR/A 0001104659-22-060818this filing2022-05-16acceptance time not in the bulk data set